The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting is taking place in Washington, D.C., and virtually from 13-15 October 2021. The world’s largest meeting dedicated solely to cancer immunotherapy brings together stakeholders across the field to share research breakthroughs and educational updates to improve outcomes for cancer patients.

VJHemOnc caught up with the presenters on new research studies and clinical trials. Move videos coming soon!

 

SITC 2021

SITC 2021
10–14 November 2021 | Washington D.C.

#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:

👉http://ow.ly/70he50KOSG1👈

#MPNsm #HemOnc #BloodCancerAwarenessMonth

We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:

🎥: http://ow.ly/ibfm50KOSf3

@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth

We're pleased to bring you another podcast! 🤩

Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.

🎧: http://ow.ly/2Top50KQC0l

#MMsm #HemOnc #ImmunoOnc

Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩‍⚕️👨‍⚕️

You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more!

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm

Load More...

SITC 2021

SITC 2021
10–14 November 2021 | Washington D.C.

The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting is taking place in Washington, D.C., and virtually from 13-15 October 2021. The world’s largest meeting dedicated solely to cancer immunotherapy brings together stakeholders across the field to share research breakthroughs and educational updates to improve outcomes for cancer patients.

VJHemOnc caught up with the presenters on new research studies and clinical trials. Move videos coming soon!

 

#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:

👉http://ow.ly/70he50KOSG1👈

#MPNsm #HemOnc #BloodCancerAwarenessMonth

We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:

🎥: http://ow.ly/ibfm50KOSf3

@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth

We're pleased to bring you another podcast! 🤩

Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.

🎧: http://ow.ly/2Top50KQC0l

#MMsm #HemOnc #ImmunoOnc

Join us this week in Houston, TX, as we interview experts & bring you exclusive discussions from #SOHO22! 👩‍⚕️👨‍⚕️

You won't want to miss out - follow us @VJHemOnc or visit http://VJHemOnc.com for more!

@SocietyofHemOnc #MMsm #LeuSM #AMLsm #ALLsm #LymSM #MDSsm #MPNsm #CLLsm

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter